Congrats to the team @ReactWise on the $3.4M round! ReactWise's copilot for chemical process optimization enables AI-driven robotic laboratories and speeds up pharmaceutical manufacturing R&D. https://t.co/Gu6WU1JI26
Revolutionizing Biotech with AI-Powered Molecular Biology Tools: Learn how TeselaGen is making a difference in fields such as drug discovery, synthetic biology, and gene therapy. https://t.co/zxPm7T62Gm #synbio #biopharma #MolecularBiology #MolBiol
YC-backed ReactWise is applying AI to speed up drug manufacturing: https://t.co/WFtjB90adC by TechCrunch #infosec #cybersecurity #technology #news
ReactWise, a startup backed by Y Combinator, has raised $3.4 million to enhance drug manufacturing processes through artificial intelligence. The company aims to optimize chemical processes and develop AI-driven robotic laboratories, thereby accelerating research and development in the pharmaceutical sector. This initiative is part of a broader trend in biotechnology, as companies like TeselaGen are also leveraging AI to advance drug discovery, synthetic biology, and gene therapy. The intersection of AI and drug manufacturing is expected to improve the efficiency of producing life-saving medications.